Blue Trust Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88K Sell
266
-18
-6% -$6.13K ﹤0.01% 1083
2025
Q4
$113K Sell
284
-65
-19% -$28.8K ﹤0.01% 996
2025
Q3
$159K Sell
349
-944
-73% -$384K ﹤0.01% 889
2025
Q2
$422K Buy
1,293
+135
+12% +$37.4K 0.01% 511
2025
Q1
$313K Buy
1,158
+293
+34% +$75.3K ﹤0.01% 553
2024
Q4
$204K Buy
865
+403
+87% +$106K ﹤0.01% 652
2024
Q3
$112K Buy
462
+375
+431% +$97.6K ﹤0.01% 1158
2024
Q2
$13K Buy
87
+72
+480% +$11.4K ﹤0.01% 1833
2024
Q1
$2.24K Sell
15
-27
-64% -$4.5K ﹤0.01% 1803
2023
Q4
$7K Sell
42
-59
-58% -$10.1K ﹤0.01% 1692
2023
Q3
$19K Buy
101
+10
+11% +$1.91K ﹤0.01% 1191
2023
Q2
$18K Sell
91
-15
-14% -$2.97K ﹤0.01% 1075
2023
Q1
$25K Sell
106
-2
-2% -$420 ﹤0.01% 1282
2022
Q4
$21K Buy
108
+87
+414% +$18.6K ﹤0.01% 1271
2022
Q3
$3K Buy
21
+8
+62% +$1.53K ﹤0.01% 1661
2022
Q2
$2K Buy
+13
New +$1.84K ﹤0.01% 1625

Other funds holding ALNY